Combination Pharmacotherapy for Methamphetamine Dependence: Extended Release Depot Naltrexone + Bupropion vs. Matched Placebos (ADAPT-MD)
This study will investigate the safety and efficacy of a combination pharmacotherapy – extended-release depot naltrexone plus extended-release bupropion for the treatment of methamphetamine dependence. The double-blind, placebo-controlled study includes random assignment of methamphetamine-dependent participants to one of two conditions: active medication or placebo for 8 weeks of pharmacotherapy provided with weekly psychosocial treatment.
Attention
Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at
Looking for Treatment?
Use the SAMHSA Treatment Locator or 1-800-662-HELP.
Helpline open during government shutdown
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.
